Related Experiment Video
Updated: May 23, 2026
08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Mesoporous silica nanoparticles with manipulated microstructures for drug delivery
Zhongdong Chen1, Xiang Li, Haiyan He
1State Key Laboratory of Silicon Materials, Department of Materials Science and Engineering, Zhejiang University, Hangzhou 310027, PR China.
Colloids and Surfaces. B, Biointerfaces
|April 13, 2012
Summary
Mesoporous silica nanoparticles (MSNs) were synthesized with tunable structures for drug delivery. Drug loading depends on surface area, while release rate is governed by pore characteristics.
Area of Science:
- Materials Science
- Nanotechnology
- Pharmaceutical Sciences
Background:
- Mesoporous silica nanoparticles (MSNs) are promising for drug delivery due to their high surface area and tunable porosity.
- Controlling the synthesis of MSNs is crucial for optimizing their performance in drug encapsulation and release.
Purpose of the Study:
- To investigate the synthesis of mesoporous silica nanoparticles (MSNs) with controlled microstructural characteristics.
- To explore the relationship between surfactant concentration and MSN structural evolution.
- To evaluate the in vitro drug release kinetics of ibuprofen (IBU) from MSNs.
Main Methods:
- Binary surfactant templated synthesis approach using varying concentrations of Pluronic F127.
- Characterization of MSN microstructural properties.
- In vitro drug loading and release studies using ibuprofen as a model drug.
Main Results:
- MSNs with controlled microstructures were successfully synthesized by adjusting Pluronic F127 concentration.
- Drug loading capacity was primarily influenced by the specific surface area of the MSNs.
- Drug release rate was predominantly determined by the length and curvature of the mesopores.
Conclusions:
- The study elucidates key factors governing drug release from MSNs, linking synthesis parameters to performance.
- A facile method for preparing MSNs with tailored structural characteristics for drug delivery applications is demonstrated.
- Understanding these structure-property relationships is vital for designing advanced MSN-based drug delivery systems.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...